Dare Bioscience, Inc. (DARE) stock
DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.43−0.16 (-26.57%)
Close on Nov 17, 2026Market cap $6.56MP/E –Yield –
Dare Bioscience enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Dare Bioscience's enterprise value was -$2.09M on Nov 11, 2026, against $2.57M a year earlier. Over the last 5 years it ranged from -$2.09M to $411.24M, with a median of $25.08M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$2.09M | -154.7% |
| 2025 | Dec 31, 2025 | $3.82M | -75.3% |
| 2024 | Dec 31, 2024 | $15.43M | -6.4% |
| 2023 | Dec 29, 2023 | $16.48M | -43.7% |
| 2022 | Dec 30, 2022 | $29.29M | -72.8% |
| 2021 | Dec 31, 2021 | $107.64M | +171.5% |
| 2020 | Dec 31, 2020 | $39.64M | +252.5% |
| 2019 | Dec 31, 2019 | $11.25M | – |
| 2018 | Dec 31, 2018 | -$1.42M | -131.2% |
| 2017 | Dec 29, 2017 | $4.56M | -76.5% |
| 2016 | Dec 30, 2016 | $19.38M | – |
| 2015 | Dec 31, 2015 | -$1.06M | -101.6% |
| 2014 | Dec 31, 2014 | $67.39M | – |
See a number that looks wrong?